Harbor Capital Advisors Inc. lessened its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 2.0% in the fourth quarter, according to its most recent filing with the SEC.
Some results have been hidden because they may be inaccessible to you